The Asia Pacific Plasma Fractionation Market would witness market growth of 11.7% CAGR during the forecast period (2021-2027). Asia-Pacific displays attractive opportunities for leading players operating in the plasma fractionation market. This is due to the existence of governmental bodies that control and manage plasma collection, fractionation, and sales are the primary aspects that are fueling the growth of the plasma fractionation market. Moreover, increasing cases of medical conditions like high fever with thrombocytopenia syndrome (SFTS), hemophilia, and primary & secondary immune deficiencies also propel the development of the market.
Moreover, the surging geriatric population, increasing government support through Medicaid and healthcare policies, and improvements in the healthcare units are some of the determinants for the growth of the plasma fractional market. In addition, key makers are aiming to expand their geographical presence in developing countries of APAC to exploiter the untapped opportunities. This, in turn, would support the growth of the regional plasma fractionation market.
In addition, the plasma fractionation market would witness bright growth prospects due to a surge in the usage of immunoglobulins and alpha-1-antitrypsin in different domains of medicine across the globe. Moreover, untapped growth opportunities in developing countries would present various attractive possibilities for the growth of the global market during the forecast period. On the other hand, the growth of the would be hampered by the huge price of plasma-derived products.
The Immunoglobulins market dominated the Singapore Plasma Fractionation Market by Product in 2020, thereby, achieving a market value of $284.7 Million by 2027. The Albumin market is showcasing a CAGR of 11.8% during (2021 - 2027). Additionally, The Coagulation factor VIII market is expected to witness highest CAGR of 13.9% during (2021 - 2027).
Based on Product, the market is segmented into Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX. Based on Sector, the market is segmented into Private Sector and Public Sector. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Plasma Fractionation Market is Projected to reach USD 28.2 Billion by 2027, at a CAGR of 9.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Emergent BioSolutions, Inc., CSL Limited, Grifols S.A., Octapharma AG, Takeda Pharmaceutical Company Limited, Kedrion S.p.A, LFB S.A, Biotest AG (Tiancheng International Investment Limited), Sanquin Blood Supply Foundation, and Bio Products Laboratory Limited.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
By Sector
- Private Sector
- Public Sector
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Emergent BioSolutions, Inc.
- CSL Limited
- Grifols S.A.
- Octapharma AG
- Takeda Pharmaceutical Company Limited
- Kedrion S.p.A
- LFB S.A
- Biotest AG (Tiancheng International Investment Limited)
- Sanquin Blood Supply Foundation
- Bio Products Laboratory Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Plasma Fractionation Market, by Product
1.4.2 Asia Pacific Plasma Fractionation Market, by Sector
1.4.3 Asia Pacific Plasma Fractionation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Plasma Fractionation Market by Product
3.1 Asia Pacific Immunoglobulins Market by Country
3.2 Asia Pacific Albumin Market by Country
3.3 Asia Pacific Coagulation factor VIII Market by Country
3.4 Asia Pacific Coagulation factor IX Market by Country
Chapter 4. Asia Pacific Plasma Fractionation Market by Sector
4.1 Asia Pacific Private Sector Market by Country
4.2 Asia Pacific Public Sector Market by Country
Chapter 5. Asia Pacific Plasma Fractionation Market by Country
5.1 China Plasma Fractionation Market
5.1.1 China Plasma Fractionation Market by Product
5.1.2 China Plasma Fractionation Market by Sector
5.2 Japan Plasma Fractionation Market
5.2.1 Japan Plasma Fractionation Market by Product
5.2.2 Japan Plasma Fractionation Market by Sector
5.3 India Plasma Fractionation Market
5.3.1 India Plasma Fractionation Market by Product
5.3.2 India Plasma Fractionation Market by Sector
5.4 South Korea Plasma Fractionation Market
5.4.1 South Korea Plasma Fractionation Market by Product
5.4.2 South Korea Plasma Fractionation Market by Sector
5.5 Singapore Plasma Fractionation Market
5.5.1 Singapore Plasma Fractionation Market by Product
5.5.2 Singapore Plasma Fractionation Market by Sector
5.6 Malaysia Plasma Fractionation Market
5.6.1 Malaysia Plasma Fractionation Market by Product
5.6.2 Malaysia Plasma Fractionation Market by Sector
5.7 Rest of Asia Pacific Plasma Fractionation Market
5.7.1 Rest of Asia Pacific Plasma Fractionation Market by Product
5.7.2 Rest of Asia Pacific Plasma Fractionation Market by Sector
Chapter 6. Company Profiles
6.1 Emergent BioSolutions, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Grifols S.A.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.1 Recent strategies and developments:
6.3.1.1 Acquisition and Mergers:
6.4 Octapharma AG
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Approvals:
6.4.2.2 Partnerships, Collaborations, and Agreements:
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Kedrion S.p.A
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 LFB S.A.
6.7.1 Company Overview
6.8 Biotest AG (Tiancheng International Investment Limited)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Sanquin Blood Supply Foundation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Bio Products Laboratory Limited
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Product Launches and Product Expansions:
TABLE 1 Asia Pacific Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 3 Asia Pacific Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 4 Asia Pacific Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 5 Asia Pacific Immunoglobulins Market by Country, 2017 - 2020, USD Million
TABLE 6 Asia Pacific Immunoglobulins Market by Country, 2021 - 2027, USD Million
TABLE 7 Asia Pacific Albumin Market by Country, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Albumin Market by Country, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Coagulation factor VIII Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Coagulation factor VIII Market by Country, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Coagulation factor IX Market by Country, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Coagulation factor IX Market by Country, 2021 - 2027, USD Million
TABLE 13 Asia Pacific Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Private Sector Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Private Sector Market by Country, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Public Sector Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Public Sector Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Plasma Fractionation Market by Country, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Plasma Fractionation Market by Country, 2021 - 2027, USD Million
TABLE 21 China Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 22 China Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 23 China Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 24 China Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 25 China Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 26 China Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 27 Japan Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 28 Japan Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 29 Japan Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 30 Japan Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 31 Japan Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 32 Japan Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 33 India Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 34 India Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 35 India Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 36 India Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 37 India Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 38 India Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 39 South Korea Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 40 South Korea Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 41 South Korea Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 42 South Korea Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 43 South Korea Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 44 South Korea Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 45 Singapore Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 46 Singapore Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 47 Singapore Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 48 Singapore Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 49 Singapore Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 50 Singapore Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 51 Malaysia Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 52 Malaysia Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 53 Malaysia Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 54 Malaysia Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 55 Malaysia Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 56 Malaysia Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 57 Rest of Asia Pacific Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 58 Rest of Asia Pacific Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 59 Rest of Asia Pacific Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 60 Rest of Asia Pacific Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 61 Rest of Asia Pacific Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 62 Rest of Asia Pacific Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 63 Key Information – Emergent BioSolutions, Inc.
TABLE 64 key Information – CSL Limited
TABLE 65 key information – Grifols S.A.
TABLE 66 Key Information – Octapharma AG
TABLE 67 Key Information – Takeda Pharmaceutical Company Limited
TABLE 68 key Information – Kedrion S.p.A
TABLE 69 Key Information – LFB S.A
TABLE 70 key information – Biotest AG
TABLE 71 Key Information – Sanquin Blood Supply Foundation
TABLE 72 Key Information – Bio Products Laboratory Limited
List of Figures
FIG 1 Methodology for the research